Tag: SCLC
PASSION Results Support Further Study of Camrelizumab Plus Apatinib in SCLC
By Kara Nyberg, PhD
Posted: June 24, 2020
The phase II PASSION trial sought to explore the potential synergy between immunotherapy and antiangiogenic drug therapy previously...
2019 IASLC World Conference on Lung Cancer Updates
Posted: November 12, 2019
More than 7,700 delegates from around the world attended the IASLC 2019 World Conference on Lung Cancer (WCLC). With sessions and...